These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 6884709)
1. Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect. Ginsburg CH; Dambrauskas JT; Ault KA; Falchuk ZM Gastroenterology; 1983 Oct; 85(4):846-51. PubMed ID: 6884709 [TBL] [Abstract][Full Text] [Related]
2. Natural killer cell activity in patients with inflammatory bowel disease. Egawa S; Hiwatashi N J Clin Lab Immunol; 1986 Aug; 20(4):187-92. PubMed ID: 3093683 [TBL] [Abstract][Full Text] [Related]
3. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood. Auer IO; Ziemer E; Sommer H Clin Exp Immunol; 1980 Oct; 42(1):41-9. PubMed ID: 7460390 [TBL] [Abstract][Full Text] [Related]
4. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon. Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal B lymphocytes in the peripheral blood of patients with inflammatory bowel disease. Ginsburg CH; Ault KA; Falchuk ZM Gastroenterology; 1981 Dec; 81(6):1111-4. PubMed ID: 7026345 [TBL] [Abstract][Full Text] [Related]
6. Natural, lectin- and phorbol ester-induced cellular cytotoxicity in Crohn's disease and ulcerative colitis. Aparicio-Pagés MN; Verspaget HW; Peña AS; Weterman IT; Mieremet-Ooms MA; van der Zon JM; de Bruin PA; Lamers CB J Clin Lab Immunol; 1988 Nov; 27(3):109-13. PubMed ID: 3246686 [TBL] [Abstract][Full Text] [Related]
7. Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease. Brown TE; Bankhurst AD; Strickland RG J Clin Lab Immunol; 1983 Jul; 11(3):113-7. PubMed ID: 6224936 [TBL] [Abstract][Full Text] [Related]
8. In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD. Lyanga JJ; Davis P; Thomson AB Clin Exp Immunol; 1979 Jul; 37(1):120-5. PubMed ID: 314871 [TBL] [Abstract][Full Text] [Related]
9. Immunological studies on Crohn's disease. III. Defective natural killer activity. Okabe N; Fujita K; Yao T J Clin Lab Immunol; 1985 Jul; 17(3):143-6. PubMed ID: 4046002 [TBL] [Abstract][Full Text] [Related]
10. Alteration in T lymphocyte subpopulations in inflammatory bowel disease. Victorino RM; Hodgson HJ Clin Exp Immunol; 1980 Jul; 41(1):156-65. PubMed ID: 6969150 [TBL] [Abstract][Full Text] [Related]